Neonatal herpes simplex virus infection: Epidemiology and treatment

Clinics in Perinatology

Volumn 42, Issue 1, 2015, Pages 47-59

  James, Scott H ^a   Kimberlin, David W ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham and Children's Hospital   (United States)

Author keywords

Antiviral therapy; Genital herpes; Herpes simplex virus; Mother to child transmission; Neonatal herpes; Polymerase chain reaction; Pregnancy

Indexed keywords

ACICLOVIR; VIRUS DNA; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; CLINICAL FEATURE; GENITAL HERPES; GENITAL TRACT INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INFECTION RISK; MATERNAL DISEASE; NEONATL HERPES SIMPLEX VIRUS INFECTION; NEWBORN; POLYMERASE CHAIN REACTION; REVIEW; SEROPREVALENCE; VIRUS TRANSMISSION; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPES GENITALIS; KERATITIS, HERPETIC; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; VERTICAL TRANSMISSION;

ACYCLOVIR; ANTIVIRAL AGENTS; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KERATITIS, HERPETIC; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84922341956     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2014.10.005     Document Type: Review

References (43)

1. Akhtar J., Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 2009, 276(24):7228-7236.
2. Roizman B., Knipe D.M., Whitley R.J. Herpes simplex viruses. Fields virology 2007, 2501-2601. Lippincott, Williams, & Wilkins, Philadelphia. 5th edition. D.M. Knipe, P.M. Howley (Eds.).
3. Roizman B. The structure and isomerization of herpes simplex virus genomes. Cell 1979, 16(3):481-494.
4. Buchman T.G., Roizman B., Adams G., et al. Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. JInfect Dis 1978, 138(4):488-498.
5. Umene K., Kawana T. Divergence of reiterated sequences in a series of genital isolates of herpes simplex virus type 1 from individual patients. JGen Virol 2003, 84(Pt 4):917-923.
6. Whitley R.J. Herpes simplex virus. Infections in the central nervous system 2004, 123-144. Lippincott Williams & Wilkins, Philadelphia. 3rd edition. M.W. Scheld, R.J. Whitley, C.M. Marra (Eds.).
7. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. JInfect Dis 2002, 186(Suppl 1):S3-S28.
8. Nahmias A.J., Lee F.K., Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990, 69:19-36.
9. Tunback P., Bergstrom T., Andersson A.S., et al. Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand J Infect Dis 2003, 35(8):498-502.
10. Corey L. Herpes simplex virus. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 2005, 1762-1780. Elsevier Churchill Livingstone, Philadelphia. 6th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
11. Corey L., Wald A., Celum C.L., et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. JAcquir Immune Defic Syndr 2004, 35(5):435-445.
12. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. NEngl J Med 1997, 337(16):1105-1111.
13. Xu F., Sternberg M.R., Kottiri B.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296(8):964-973.
14. Bradley H., Markowitz L.E., Gibson T., et al. Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999-2010. JInfect Dis 2014, 209(3):325-333.
15. Bernstein D.I., Bellamy A.R., Hook E.W., et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013, 56(3):344-351.
16. Roberts C.M., Pfister J.R., Spear S.J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003, 30(10):797-800.
17. Kimberlin D.W. The scarlet H. JInfect Dis 2013, 209(3):315-317.
18. ACOG Committee on Practice Bulletins ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007, 109(6):1489-1498.
19. Kulhanjian J.A., Soroush V., Au D.S., et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. NEngl J Med 1992, 326(14):916-920.
20. Kucera P., Gerber S., Marques-Vidal P., et al. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study. Eur J Obstet Gynecol Reprod Biol 2012, 160(1):13-17.
21. Sheffield J.S., Hill J.B., Hollier L.M., et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006, 108(1):141-147.
22. Watts D.H., Brown Z.A., Money D., et al. Adouble-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003, 188(3):836-843.
23. Brown Z.A., Selke S., Zeh J., et al. The acquisition of herpes simplex virus during pregnancy. NEngl J Med 1997, 337(8):509-515.
24. Yeager A.S., Arvin A.M. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984, 73(2):188-193.
25. Whitley R.J., Nahmias A.J., Visintine A.M., et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980, 66(4):489-494.
26. Whitley R.J., Corey L., Arvin A., et al. Changing presentation of herpes simplex virus infection in neonates. JInfect Dis 1988, 158(1):109-116.
27. Brown Z.A., Wald A., Morrow R.A., et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003, 289(2):203-209.
28. Kropp R.Y., Wong T., Cormier L., et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006, 117(6):1955-1962.
29. Jones C.A., Raynes-Greenow C., Issacs D. Population-based surveillance of neonatal HSV infection in Australia (1997-2011). Clin Infect Dis 2014, 59(4):525-531.
30. Brown Z.A., Benedetti J., Ashley R., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. NEngl J Med 1991, 324(18):1247-1252.
31. Arvin A.M., Hensleigh P.A., Prober C.G., et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. NEngl J Med 1986, 315(13):796-800.
32. Pinninti S.G., Kimberlin D.W. Maternal and neonatal herpes simplex virus infections. Am J Perinatol 2013, 30(2):113-119.
33. Hutto C., Arvin A., Jacobs R., et al. Intrauterine herpes simplex virus infections. JPediatr 1987, 110(1):97-101.
34. Baldwin S., Whitley R.J. Intrauterine herpes simplex virus infection. Teratology 1989, 39(1):1-10.
35. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108(2):223-229.
36. Whitley R.J., Roizman B. Herpes simplex viruses. Clinical virology 2004, 375-401. ASM Press, Washington, DC. 2nd edition. D.D. Richman, R.J. Whitley, F.G. Hayden (Eds.).
37. Sheffield J.S., Hollier L.M., Hill J.B., et al. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003, 102:1396-1403.
38. Pinninti S.G., Angara R., Feja K.N., et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. JPediatr 2012, 161(1):134-138.e1-e3.
39. Kimberlin D.W., Baley J., Committee on Infectious Diseases, Committee on Fetus and Newborn Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 2013, 131(2):383-386.
40. Whitley R.J., Nahmias A.J., Soong S.J., et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980, 66(4):495-501.
41. Whitley R., Arvin A., Prober C., et al. Acontrolled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. NEngl J Med 1991, 324(7):444-449.
42. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001, 108(2):230-238.
43. Kimberlin D.W., Whitley R.J., Wan W., et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. NEngl J Med 2011, 365(14):1284-1292.